GeneDx Holdings Corp.
WGS
$86.48
$0.610.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 10.45% | -13.63% | |||
| Total Other Revenue | 167.43% | -74.21% | |||
| Total Revenue | 11.92% | -15.48% | |||
| Cost of Revenue | 6.20% | -7.28% | |||
| Gross Profit | 14.77% | -19.06% | |||
| SG&A Expenses | 1.94% | 2.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.65% | -4.02% | |||
| Operating Income | 33.52% | -104.08% | |||
| Income Before Tax | 70.75% | -242.40% | |||
| Income Tax Expenses | -157.75% | 259.04% | |||
| Earnings from Continuing Operations | 71.98% | -258.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 71.98% | -258.41% | |||
| EBIT | 33.52% | -104.08% | |||
| EBITDA | 44.81% | -182.89% | |||
| EPS Basic | 72.34% | -254.94% | |||
| Normalized Basic EPS | 26.81% | -52.91% | |||
| EPS Diluted | 72.20% | -254.94% | |||
| Normalized Diluted EPS | 26.81% | -52.91% | |||
| Average Basic Shares Outstanding | 1.28% | 0.98% | |||
| Average Diluted Shares Outstanding | 1.28% | 0.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||